Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
University of Essex Enterprises Limited currently has 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 2 actions are split between 2 distinct examiners and 2 distinct art units. RIGGS II, LARRY D is identified as the busiest examiner with 1 pending office action. This 1:1 ratio between pending actions and examiners suggests a diversified prosecution across different technical sub-specialties or art units.
The 2 pending office actions are distributed across 2 distinct art units, indicating that the company is pursuing multiple technical paths within the Biotechnology & Pharmaceuticals sector. With 2 distinct examiners involved, the company must manage two separate prosecution timelines. RIGGS II, LARRY D handles 1 pending office action, which is the same volume as the other examiner. This lack of concentration across 2 distinct examiners and 2 distinct art units means that the outcome of each of the 2 pending office actions is independent of the other.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RIGGS II, LARRY D | 1 | 46.3% | +32.2% |
| SPEED, DEQUANTARIUS JAVON | 1 | 70.0% | +69.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17438792 | METHODS OF ENHANCING BIOMASS IN A PLANT THROUGH STIMULATION OF RUBP REGENERATION AND ELECTRON TRANSPORT | SPEED, DEQUANTARIUS JAVON | 4d overdue |
| 18563324 | METHOD AND SYSTEM FOR IDENTIFYING GENOMIC REGIONS WITH CONDITION SENSITIVE OCCUPANCY/POSITIONING OF NUCLEOSOMES AND/OR CHROMATIN | RIGGS II, LARRY D | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17438792 | METHODS OF ENHANCING BIOMASS IN A PLANT THROUGH STIMULATION OF RUBP REGENERATION AND ELECTRON TRANSPORT | SPEED, DEQUANTARIUS JAVON | 4d overdue |
| 18563324 | METHOD AND SYSTEM FOR IDENTIFYING GENOMIC REGIONS WITH CONDITION SENSITIVE OCCUPANCY/POSITIONING OF NUCLEOSOMES AND/OR CHROMATIN | RIGGS II, LARRY D | — |
| Art Unit | Apps |
|---|---|
| 1686 | 1 |
| 1663 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18563324 | METHOD AND SYSTEM FOR IDENTIFYING GENOMIC REGIONS WITH CONDITION SENSITIVE OCCUPANCY/POSITIONING OF NUCLEOSOMES AND/OR CHROMATIN | RIGGS II, LARRY D | 1686 | §101 | Non-Final OA | — | Pending | Nov 21, 2023 |
| 17438792 | METHODS OF ENHANCING BIOMASS IN A PLANT THROUGH STIMULATION OF RUBP REGENERATION AND ELECTRON TRANSPORT | SPEED, DEQUANTARIUS JAVON | 1663 | §103§112 | Non-Final OA | 4d overdue | Pending | Sep 13, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversity of Essex Enterprises Limited has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Larry D Riggs II has the most, with 1 of University of Essex Enterprises Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
